BackFidelity Select Pharmaceuticals Overview

Fidelity Select Pharmaceuticals Receivables

Fidelity Select Pharmaceuticals's receivables is $17M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$17.19M

Peer trimmed avg / median

Loading

Fidelity Select Pharmaceuticals Receivables History

Loading

Fidelity Select Pharmaceuticals vs. peers: Receivables Comparison

Loading

Fidelity Select Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Pharmaceuticals (FPHAX) FAQ

As of the most recent data (October 2023), FPHAX shows a receivables of $17M. Scroll down for historical charts and peer comparison views.

Tracking FPHAX's receivables over time shows whether Fidelity Select Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $17M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Fidelity Select Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $17M) with ownership activity and broader fundamentals.